Back to Journals » Journal of Blood Medicine » Volume 12

Profile and Management of Toxicity of Selinexor and Belantamab Mafodotin for the Treatment of Triple Class Refractory Multiple Myeloma

Total article views   HTML views PDF downloads Totals
6,339 Dovepress* 4,631+ 640 5,271
PubMed Central* 1,708 301 2,009
Totals 6,339 941 7,280
*Since 1 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 7 7

View citations on PubMed Central and Google Scholar